tradingkey.logo

Zai Lab Ltd

ZLAB
View Detailed Chart

36.820USD

-0.980-2.59%
Close 08/01, 16:00ETQuotes delayed by 15 min
3.99BMarket Cap
LossP/E TTM

Zai Lab Ltd

36.820

-0.980-2.59%
Intraday
1m
30m
1h
D
W
M
D

Today

-2.59%

5 Days

-0.94%

1 Month

+1.15%

6 Months

+34.48%

Year to Date

+40.59%

1 Year

+102.20%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 12 analysts
BUY
Current Rating
55.483
Target Price
50.69%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

173
Total
5
Median
8
Average
Company name
Ratings
Analysts
Zai Lab Ltd
ZLAB
12
Biogen Inc
BIIB
37
Vertex Pharmaceuticals Inc
VRTX
34
Alnylam Pharmaceuticals Inc
ALNY
34
Amgen Inc
AMGN
33
Gilead Sciences Inc
GILD
30
1
2
3
...
35

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(5)
Neutral(2)
Buy(5)
Indicators
Sell(3)
Neutral(2)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.353
Buy
RSI(14)
50.982
Neutral
STOCH(KDJ)(9,3,3)
42.455
Sell
ATR(14)
1.888
High Vlolatility
CCI(14)
-22.826
Neutral
Williams %R
57.255
Sell
TRIX(12,20)
0.287
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
38.478
Sell
MA10
37.636
Sell
MA20
36.188
Buy
MA50
35.842
Buy
MA100
34.157
Buy
MA200
31.317
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Zai Lab Ltd is a holding company primarily engaged in biopharmaceuticals. The Company is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The Company has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
Ticker SymbolZLAB
CompanyZai Lab Ltd
CEODr. Du (Samantha) Ying, Ph.D.
Websitehttps://www.zailaboratory.com/
KeyAI